Champions Oncology (STU:2I3) Shares Buyback Ratio % : -0.26 (As of May. 19, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Champions Oncology Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Champions Oncology's current shares buyback ratio was -0.26%.

Champions Oncology Shares Buyback Ratio % Historical Data

The historical data trend for Champions Oncology's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Champions Oncology Shares Buyback Ratio % Chart

Champions Oncology Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-5.60

-9.53

-5.40

-0.81

-0.16

Champions Oncology Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	0.11	0.44	-0.81	-

Champions Oncology Shares Buyback Ratio % Calculation

Champions Oncology's Shares Buyback Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Apr. 2022 )	-	Shares Outstanding (EOP) (A: Apr. 2023 ))	/	Shares Outstanding (EOP) (A: Apr. 2022 )
	=	(13.5224	-	13.5442)	/	13.5224
	=	-0.16%

Champions Oncology's Shares Buyback Ratio for the quarter that ended in Jan. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Oct. 2023 )	-	Shares Outstanding (EOP) (A: Jan. 2024 ))	/	Shares Outstanding (EOP) (A: Oct. 2023 )
	=	(13.5938	-	13.5938)	/	13.5938
	=	0.00%

Champions Oncology Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Champions Oncology's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Champions Oncology (STU:2I3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Champions Oncology Inc (STU:2I3) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

CSBR:USA 2I3:Germany

Address

One University Plaza, Suite 307, Hackensack, NJ, USA, 07601

Website

https://www.championsoncology.com

Champions Oncology Inc is a us-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies.

Champions Oncology (STU:2I3) Headlines

No Headlines